x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




Janssen sues Hetero over generic HIV treatment

14-03-2013

Janssen Products, a subsidiary of Johnson & Johnson, has sued Indian pharmaceutical company Hetero Drugs for applying to market a generic version of its HIV treatment Prezista.


Janssen, Tibotec, Johnson & Johnson, generic, Prezista, patent

WIPR

Payment types accepted